Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
47371
CAS Number:
54573-75-0
Doxercalciferol
Purity:
≥ 98 % (HPLC)
Synonym(s):
(5 Z , 7 E , 22 E ) -9,10-Secoergosta-5,7,10,22-tetraeno-1,3-diol
Hazmat
Documents
$320.40 /5 mg
Tamaño
Request Bulk Quote
Información del producto
Número CAS
54573-75-0
Fórmula molecular
C28H44O2
Peso molecular
0
Número MDL
MFCD00871065
Punto de fusión
139 - 141 °C
Densidad
1.020
Índice de refracción
1.540
Rotación óptica
[a] D 20 = 45 - 50 ° (C = 0,5 en etanol)
Condiciones
Conservar a < -10 °C, desecado.
Información general
Número CAS
54573-75-0
Fórmula molecular
C28H44O2
Peso molecular
0
Número MDL
MFCD00871065
Punto de fusión
139 - 141 °C
Densidad
1.020
Índice de refracción
1.540
Rotación óptica
[a] D 20 = 45 - 50 ° (C = 0,5 en etanol)
Condiciones
Conservar a < -10 °C, desecado.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Doxercalciferol is widely utilized in research focused on:

  • Chronic Kidney Disease Management: This compound is primarily used to manage secondary hyperparathyroidism in patients with chronic kidney disease, helping to regulate calcium and phosphate levels effectively.
  • Bone Health Research: Researchers study its effects on bone mineralization and density, making it valuable in osteoporosis studies and treatments aimed at improving bone health.
  • Endocrine System Studies: Doxercalciferol plays a crucial role in research related to vitamin D metabolism and its effects on the endocrine system, providing insights into hormonal regulation.
  • Pharmaceutical Development: It is an important compound in the development of new medications targeting vitamin D deficiency, offering potential advantages over traditional vitamin D therapies.
  • Clinical Trials: Frequently used in clinical trials to evaluate its efficacy and safety in various patient populations, contributing to evidence-based medicine and improved patient outcomes.

Citas